Vol 15, No 1 (2011) > Articles >

Production of Lovastatin and Sulochrin by Aspergillus Terreus Using Solid State Fermentation

Rizna Dewi 1 , Nina Artanti 1 , Hani Mulyani 1 , Puspa Lotulung 1 , Minarti Minarti 1

Affiliations:

  1. Research Center of Chemistry, Indonesian Institute of Scinces, Kawasan Puspiptek Serpong, Tangerang 15314, Indonesia

 

Abstract:

Lovastatin is an anti-cholesterol agent that was produced by Aspergillus terreus using solid state fermentation (SSF). During this fermentation process, sulochrin is also produced as an unwanted co-metabolite. However, our previous result showed that sulochrin had potential as antidiabetes because it is an inhibitor agent of α-glucosidase. In this paper, we reported our observation on lovastatin and sulochrin production pattern in relation with inhibitor α-glucosidase activity during eleven days fermentation of A. terreus koji (SSF) ethyl acetate extract. Koji obtained from solid state fermentation with rice as the substrate and incubated at room temperature, sample is taken daily for eleven day (D-1 to D-11). Lovastatin and sulochrin production was measured by Liquid Chromatography- Mass Spectrometer based on their molecular weight m/z 404.5 and 332.3 respectively. The inibitory activity is measured by inhibition model of koji extract against α-glucosidase (EC 3.2.1.20) from Saccharomyces cereviceae. The results show that lovastatin production was started on the day 2 (0.04 mg/g) and achieving the optimal production on day 7 (11.46 mg/g), while sulochrin production was started on day 4 (0.60 mg/g) and keep produced until the end of fermentation period at Day 11 (3.11 mg/g). Koji extract was started to show inhibitory to α-glucosidase activity on Day 5 (IC50= 23.34 μg/mL) and keep showed activity until Day 11 (IC50=3.33 μg/mL). These results suggest that inhibitory activity of koji extract to α- glucosidase activity have relation with sulochrin biosynthesis production.

Keywords: α-glucosidase inhibitor, Aspergillus terreus, lovastatin, SSF, sulochrin
Published at: Vol 15, No 1 (2011) pages: 1-4
DOI:

Access Counter: 1133 views, 719 PDF downloads, .

Full PDF Download

References:

A.W. Alberts, J. Chen, G. Kuron, V. Hunt, J. Huff, C. Hoffman, Proc. Natl. Acad. Sci. 77 (1980) 3957.

H.R. Valera, J. Gomes, S. Lakshmi, R. Gururaja, S. Suryanarayan, D. Kumar, Enzyme. Microb. Technol. 37/5 (2005) 521.

H. Hajjaj, N. Peter, D. Philippe, App. Environ. Microbiol. 67 (200) 2596.

M. Bizukojc, S. Ledakowicz, J. Biotechol. 132/4 (2007) 453.

J.L. Casas Lopez, J.A. Sanches Perez, J.M. Fernandez Sevilla, F.G. Acien Fernandez, E. Molina Grima, Y. Christy, Enzyme. Microb. Technol. 33/8 (2003) 270.

M.S. Kumar, S.K. Jana, V. Senthil, S. Shashanka, S.V. Kumar, A.K. Sadhukhan, Process Biochem. 36 (2000) 363.

P.L. Wei, Z.N. Xu, P.L. Cen, J. Zhejiang Univ. Sci A. 8/9 (2007) 1521.

D. Kumar, V.K. Jain, G. Shanker, A. Srivastava, Process Biochem. 38 (2003) 1725.

B.J. Xu, Q.J. Wang, X.Q. Jia, C.K. Sung, Biotechnol. Bioprocess Eng. 10/1 (2005) 78.

V.A. Vinci, T.D. Hoerner, A.D. Coffman, T.G. Schimmel, R.L. Dabora, A.C. Kirpeker, C.L. Ruby, R.W. Stieber, J. Ind. Microbiol. 8 (1991) 113.

R.D. Couch, G.M. Gaucher, J. Biotech. 108 (2004) 171.

R.T. Dewi, A. Darmawan, S.D.S. Banjarnahor, H. Mulyani, M. Angelina, Minarti, Proceeding of the International Conference on Pharmacy and Advanced Pharmaceutical Sciences, Yogyakarta, Indonesia, 2009. p. 44.

R.T. Dewi, Y. Iskandar, M. Hanafi, L.B.S. Kardono, M. Angelina, D.I. Dewijanti, S.D.S. Banjarnahor, Pak. J. Biol. Sci. 10/18 (2007) 3131.

Y.P. Zhu, L.J. Yin, Y.Q. Cheng, K. Yamaki, Y. Mori, Y.C. Su, L.T. Li, Food Chem. 109 (2008) 737.

F. Hiroyuki, Y. Tomohide, Elsevier 70 (2001) 219.

S. Sato, N. Okusa, A. Ogawa, T. Ikenoue, T. Seki, T. Tsuji, J. Antibiot. 58 (2005) 583.